Every Form 4 that Agilysys, Inc. (AGYS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AGYS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AGYS filings page.
AGILYSYS INC (AGYS) reports that Chief Commercial Officer Abdelrahman Joe Ahmed Youssef sold 1,002 shares of common stock on September 1, 2026 at $114.64 per share. The sale was executed to fund withholding tax obligations from vesting of restricted common stock and left him holding 19,045 shares directly.
AGILYSYS INC (AGYS) reported that Chief Financial Officer William David Wood III sold 6,000 shares of common stock on August 18, 2026. The sale was executed in the open market at a weighted average price of $114.72 per share, with individual trade prices ranging from $114.63 to $114.80. Following these transactions, Wood directly holds 35,052 shares of Agilysys common stock.
AGILYSYS INC (AGYS) reported that officer Kyle C. Badger, SVP, GC and Secretary, sold 8,400 shares of common stock on 2026-08-18 in an open market or private transaction. The weighted average sale price was about $114.06 per share, with actual prices ranging from $114.06 to $114.29. Following this sale, Badger directly holds 75,037 shares of AGILYSYS common stock.
AGILYSYS INC reports that President & CEO Ramesh Srinivasan sold a total of 197,410 shares of common stock in open‑market or private transactions on August 5–7, 2026. The reported per‑share prices are weighted averages from $106.60 to $109.63, and an indirect holding of 60,000 shares is reported in the Ramesh and Sujatha Srinivasan Living Trust.
SRINIVASAN RAMESH reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc reported two equity awards to President & CEO Ramesh Srinivasan on June 18, 2026, totaling 78,270 restricted stock units, each representing one share of common stock. One 39,135-unit grant vests over time starting June 18, 2028, while another 39,135-unit grant vests only if stock-price hurdles of $105, $120 and $135 are met over 20 consecutive trading days, followed by scheduled quarterly installments, all subject to continued employment.
AGILYSYS SVP, GC and Secretary Kyle C. Badger sold a total of 3,000 shares of common stock in open-market transactions. He sold 1,000 shares at $92.51 per share and 2,000 shares at $92.17 per share. A footnote notes that, since his prior Form 4, he transferred 33,206 shares to his ex-spouse under a domestic relations order, and those shares are no longer beneficially owned by him.
Agilysys, Inc. President & CEO Ramesh Srinivasan received an award of 7,570 shares of common stock at $0.00 per share, classified as a grant under the Agilysys, Inc. 2024 Equity Incentive Plan upon attainment of performance goals for the fiscal year ended March 31, 2026.
This Form 4/A amends an earlier filing to correct the number of shares acquired, which had been inadvertently reported as 8,607. Following the correction, Srinivasan is shown as directly owning 807,454 shares of common stock, with an additional 60,000 shares held indirectly through the Ramesh and Sujatha Srinivasan Living Trust.
JONES JERRY C reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc. director Jerry C. Jones received a grant of 1,424 restricted stock units (RSUs). These RSUs were awarded under the Agilysys, Inc. 2024 Equity Incentive Plan and each unit represents a contingent right to receive one share of Agilysys common stock.
The RSUs vest on May 27, 2027, meaning Jones will receive the underlying shares only if the vesting conditions are satisfied and he remains eligible through that date. Following this award, his reported direct holdings from this grant total 1,424 RSUs.
Kaufman Michael A reported acquisition or exercise transactions in this Form 4 filing.
AGILYSYS INC director Michael A. Kaufman received a grant of 1,424 restricted stock units. These units were awarded on May 27, 2026 under the Agilysys, Inc. 2024 Equity Incentive Plan and each unit represents a contingent right to receive one share of Agilysys common stock.
The restricted stock units vest on May 27, 2027, meaning Kaufman will receive the underlying common shares only if the vesting conditions are satisfied and he remains eligible on that date. This is a compensation-related equity award rather than an open-market stock purchase or sale.
Pope Lisa reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc. director Lisa Pope received a grant of 1,424 restricted stock units, each representing one share of Agilysys common stock. The award was made under the Agilysys, Inc. 2024 Equity Incentive Plan and vests on May 27, 2027. Following this grant, she holds 1,424 restricted stock units directly.
COLVIN DONALD A reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc. director Donald A. Colvin received a grant of 1,424 restricted stock units (RSUs). These RSUs were awarded at no cash cost under the Agilysys, Inc. 2024 Equity Incentive Plan, with each unit representing a contingent right to one share of common stock.
The 1,424 RSUs vest on May 27, 2027, meaning the shares are earned over time rather than immediately. After this grant, Colvin holds 1,424 RSUs directly, reflecting a routine, compensation-related equity award rather than an open-market share purchase or sale.
MUTCH JOHN reported acquisition or exercise transactions in this Form 4 filing.
Agilysys director John Mutch reported receiving a grant of 1,424 restricted stock units under the Agilysys, Inc. 2024 Equity Incentive Plan. Each unit represents a contingent right to receive one share of Agilysys common stock. These restricted stock units vest on May 27, 2027, and his reported holdings after the grant are 1,424 units.
Jones Dana Sue reported acquisition or exercise transactions in this Form 4 filing.
AGILYSYS INC director Dana Sue Jones received a grant of 1,424 restricted stock units. These RSUs were awarded under the Agilysys, Inc. 2024 Equity Incentive Plan and each unit represents one share of common stock. The units vest on May 27, 2027, aligning compensation with longer-term company performance.
KEATING MELVIN L reported acquisition or exercise transactions in this Form 4 filing.
Agilysys Inc. director Melvin L. Keating reported a compensation-related equity grant. He was awarded 1,424 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Agilysys common stock. The RSUs were granted under the Agilysys, Inc. 2024 Equity Incentive Plan and will vest on May 27, 2027, if vesting conditions are met.
SRINIVASAN RAMESH reported acquisition or exercise transactions in this Form 4 filing.
Agilysys, Inc. President & CEO Ramesh Srinivasan reported an equity award of 8,607 shares of common stock. The shares were granted at $0.00 per share under the Agilysys, Inc. 2024 Equity Incentive Plan upon attainment of certain performance goals for the fiscal year ended March 31, 2026.
Following this grant, Srinivasan directly holds 808,491 shares of common stock. Separately, an indirect line shows 60,000 shares held by the Ramesh and Sujatha Srinivasan Living Trust, reflecting additional ownership through that trust.
AGILYSYS director Jerry C. Jones exercised 973 restricted stock units into Common Stock at $79.84 per share. This compensation-related transaction increased his direct ownership to 42,923 shares of AGILYSYS Common Stock, with no open-market sale reported in this filing.
Agilysys Inc. director Dana Sue Jones exercised 973 restricted stock units into common shares. On May 22, 2026, 973 RSUs converted into 973 shares of Agilysys common stock at a stated conversion price of $79.84 per share.
Following the transaction, Jones directly holds 14,829 shares of common stock. The filing shows no open-market sale; the activity reflects a derivative exercise and corresponding issuance of common shares as equity compensation.
AGILYSYS INC director Donald A. Colvin exercised restricted stock units into common shares. On 2026-05-22, he converted 973 restricted stock units into 973 shares of common stock at an implied value of $79.84 per share.
After this compensation-related exercise, Colvin directly holds 25,565 shares of Agilysys common stock. The Form 4 does not report any open-market purchases or sales, only the derivative exercise and resulting share ownership.
AGILYSYS INC director Melvin L. Keating exercised restricted stock units into common shares. On 2026-05-22, he converted 973 Restricted Stock Units into 973 shares of Common Stock at an effective conversion price of $79.84 per share. This was a derivative exercise transaction rather than an open-market purchase or sale. Following the transaction, he directly owns 36,380 shares of Agilysys common stock. No remaining derivative positions are shown in this filing.
AGILYSYS INC director John Mutch exercised equity awards rather than trading shares in the market. On May 22, 2026, he converted 973 Restricted Stock Units into 973 shares of Common Stock at an exercise price of $79.84 per share. Following the transaction, he directly holds 32,377 shares of Common Stock. The filing shows no open-market purchases or sales, only a compensation-related derivative exercise, and no remaining derivative positions are listed after this event.
Agilysys director Lisa Pope exercised restricted stock units into common shares. On 2026-05-22, she converted 973 Restricted Stock Units into 973 shares of Agilysys common stock at a conversion price of $79.84 per share. Following the transaction, she directly owns 1,214 common shares. This was a compensation-related derivative exercise with no open-market sale reported in this filing.
Agilysys director Michael A. Kaufman exercised restricted stock units into common shares. On May 22, 2026, he converted 973 restricted stock units into 973 shares of Agilysys common stock at a stated conversion price of $79.84 per share. After these transactions, he directly holds 11,521 shares of common stock and 973 restricted stock units, reflecting a compensation-related increase in his direct equity position without any reported open-market sale.
AGILYSYS INC director Melvin L. Keating reported open-market purchases of company common stock. On March 16–17, 2026, he bought a total of 400 shares in several trades at prices between $67.98 and $68.49 per share. Following these purchases, he directly owns 35,407 shares of Agilysys common stock.
Agilysys President & CEO Ramesh Srinivasan exercised restricted stock units and performance-based restricted stock units into a total of 45,238 shares of common stock on March 10, 2026. After these equity conversions, he holds 799,884 common shares directly and 60,000 shares indirectly through the Ramesh and Sujatha Srinivasan Living Trust.
Agilysys director Melvin L. Keating increased his stake through open-market stock purchases. On January 30, 2026, he bought multiple blocks of Agilysys common stock ranging from 50 to 100 shares at prices between $83.90 and $84.84 per share.
On February 3, 2026, he made additional purchases in 30–70 share blocks at prices between $81.90 and $84.70 per share. Following the reported transactions, he directly owned 35,007 shares of Agilysys common stock.
Agilysys, Inc. (AGYS) director reported a sale of company stock. On 11/21/2025, the reporting person sold 6,000 shares of Agilysys common stock at a weighted average price of $123.28 per share, as shown in Table I of the filing. After this transaction, the director beneficially owns 24,592 shares of Agilysys common stock in direct ownership. The price is disclosed as a weighted average, and the reporting person has committed to provide details of the number of shares sold at each separate price upon request.
Agilysys (AGYS) insider transaction: An officer serving as Controller reported a sale of common stock. On 11/12/2025, the insider sold 500 shares at $131.34, recorded with transaction code “S.” Following this trade, the insider beneficially owns 687 shares directly and 20,000 shares indirectly held by The CJR Revocable Trust.
The filing indicates it was submitted by attorney-in-fact Kyle C. Badger. This is a routine ownership update that reflects a single sale and the insider’s updated holdings.
Agilysys (AGYS) insider activity: A Form 4 reports that the company’s Chief Financial Officer sold 584 shares of common stock on 11/04/2025 at $125.20 per share. After this transaction, the officer beneficially owns 41,052 shares directly.
This filing discloses a routine insider sale by an executive and updates the officer’s current direct holdings.
Agilysys (AGYS) reported an insider equity grant. The Chief Financial Officer filed a Form 4 disclosing 5,330 restricted stock units granted on 11/03/2025 under the Agilysys, Inc. 2024 Equity Incentive Plan. Each unit represents the right to receive one share of common stock.
The RSUs vest in one‑third increments on 10/31/2026, 10/31/2027, and 10/31/2028. Following the transaction, the officer beneficially owns 8,007 derivative securities as reported.
Agilysys (AGYS) filed a Form 4 reporting an equity award to its CTO. On 11/03/2025, the officer received 4,164 restricted stock units under the Agilysys, Inc. 2024 Equity Incentive Plan. Each RSU represents a right to receive one share of Agilysys common stock.
The RSUs vest in three equal installments on October 31 of 2026, 2027, and 2028. This filing records an officer compensation grant and does not describe open‑market purchases or sales.
Agilysys (AGYS) reported an insider equity award on Form 4. An officer serving as Controller received 1,666 restricted stock units (RSUs) on November 3, 2025. Each RSU represents the right to receive one share of common stock.
The RSUs vest in one-third increments on October 31, 2026, 2027, and 2028. Following this grant, the reporting person beneficially owned 2,567 derivative securities on a direct basis.
Agilysys, Inc. (AGYS) reported an insider equity award. On 11/03/2025, officer Kyle C. Badger (SVP, GC and Secretary) received 3,332 restricted stock units under the Agilysys, Inc. 2024 Equity Incentive Plan. Each RSU represents the right to receive one share of Agilysys common stock.
The RSUs vest in one-third increments on October 31, 2026, October 31, 2027, and October 31, 2028. The award price is listed as $0, consistent with RSU grants. Following the reported transaction, 4,576 derivative securities were beneficially owned, with ownership reported as direct.
Agilysys (AGYS) disclosed an insider equity award for its Chief Commercial Officer. On 11/03/2025, the officer received 3,021 restricted stock units (RSUs) under the Agilysys, Inc. 2024 Equity Incentive Plan. Each RSU represents the right to receive one share of Agilysys common stock.
The RSUs vest in one‑third increments on 10/31/2026, 10/31/2027, and 10/31/2028. The filing lists a $0 price for the derivative security. Following this grant, the officer reported 3,861 derivative securities beneficially owned, held directly.
Agilysys (AGYS) Form 4: the Chief Financial Officer reported RSU vesting and a related sale. On 10/31/2025, 1,338 Restricted Stock Units converted to common stock (code M). On 11/03/2025, 990 shares were sold at $124.64 (code S) to fund tax withholding from the vesting. After these transactions, the officer beneficially owns 41,636 common shares directly. Derivative holdings reported include 2,677 RSUs following the transaction.
Agilysys, Inc. (AGYS) reported insider equity activity by its CTO on a Form 4. On 10/31/2025, 723 Restricted Stock Units vested and converted into common stock (transaction code M). On 11/03/2025, 497 shares were sold at $124.64 in a transaction noted as a sell-to-cover for withholding taxes.
Following these transactions, 24,031 shares of common stock were held direct. The filing also lists 1,446 RSUs beneficially owned following the vesting event. A conversion price of $0 is shown for the RSUs, and the acquisition price recorded for the common shares from the RSU vesting was $125.46.
Agilysys (AGYS) officer (Controller) reported routine equity activity on a Form 4. On 10/31/2025, 450 restricted stock units vested and converted to common stock (code M) at a reported price of $125.46. On 11/03/2025, 400 shares were sold (code S) at $124.64 to fund withholding taxes related to the vesting.
Following these transactions, the officer directly held 16,187 shares, with an additional 5,000 shares held indirectly by The CJR Revocable Trust. Derivative holdings (RSUs) reported as 901 after the event.
Agilysys (AGYS) reported insider transactions by its Chief Commercial Officer. The filing shows two tax-related sales and one restricted stock unit conversion. On 09/02/2025, 504 shares of Common Stock were sold at $106.88 to cover withholding from an 08/31 vest. On 10/31/2025, 419 RSUs converted to Common Stock at $0 (code M). On 11/03/2025, 103 shares were sold at $124.64 to cover withholding from the 10/31 vest.
Following these transactions, the officer directly owned 20,047 Common Stock shares. Derivative holdings listed include 840 RSUs.
Agilysys (AGYS) officer Kyle C. Badger reported an RSU vesting and a related sale on Form 4. On 10/31/2025, 622 shares were acquired upon the vesting of Restricted Stock Units. On 11/03/2025, 502 shares were sold at $124.64 per share.
Following these transactions, Badger directly owned 114,911 shares. The filing notes the sale was to fund withholding tax obligations arising from the RSU vesting.
Agilysys, Inc. (AGYS) reported an insider transaction: the Chief Financial Officer sold 6,000 shares of common stock on 10/27/2025, coded “S” for sale. The weighted average price was $115.55, with individual trades executed between $113.85 and $117.04.
Following the sale, the reporting person beneficially owned 41,288 shares, held directly. The filing notes the price is a weighted average and that full breakdowns of each trade price within the stated range are available upon request.